Page 4 - Thomas Sandgaard News Today

Zynex (NASDAQ:ZYXI – Get Rating) updated its FY 2023 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.40-$0.50 for the period, compared to the consensus estimate of $0.47. The company issued revenue guidance of $180.00 million-$200.00 million, compared to the consensus revenue estimate of $191.24 million. Zynex also updated its […]

Zynex (NASDAQ:ZYXI – Get Rating) issued an update on its first quarter 2023 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0-$0.03 for the period, compared to the consensus earnings per share estimate of $0.01. The company issued revenue guidance of $39.00 million-$41.00 million, compared to the consensus revenue estimate […]

/PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the "Selling Stockholder"), has...

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

/PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million...

Shares of Zynex, Inc. (NASDAQ:ZYXI – Get Rating) saw unusually-strong trading volume on Monday . Approximately 493,667 shares traded hands during trading, an increase of 97% from the previous session’s volume of 250,735 shares.The stock last traded at $13.94 and had previously closed at $11.44. Analyst Upgrades and Downgrades A number of equities research analysts […]

Janney Montgomery Scott LLC cut its stake in shares of Zynex, Inc. (NASDAQ:ZYXI – Get Rating) by 43.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 64,655 shares of the company’s stock after selling 49,388 shares during the quarter. Janney Montgomery Scott […]

Zynex (NASDAQ:ZYXI – Get Rating) issued an update on its second quarter 2023 earnings guidance on Thursday morning. The company provided EPS guidance of $0.03-$0.07 for the period, compared to the consensus EPS estimate of $0.08. The company issued revenue guidance of $43.50 million-$45.50 million, compared to the consensus revenue estimate of $44.56 million. Zynex […]

Zynex (NASDAQ:ZYXI – Get Rating) issued an update on its second quarter 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.03-$0.07 for the period, compared to the consensus earnings per share estimate of $0.08. The company issued revenue guidance of $43.50 million-$45.50 million, compared to the consensus revenue estimate […]

Should You Buy or Sell Zynex Stock? Get The Latest ZYXI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.